Status:
COMPLETED
Cough Frequency in Chronic Obstructive Pulmonary Disease
Lead Sponsor:
Hull University Teaching Hospitals NHS Trust
Collaborating Sponsors:
Philips Respironics
Conditions:
COPD Exacerbation
Eligibility:
All Genders
40-80 years
Brief Summary
Acute exacerbations of COPD remain a common cause of morbidity and are associated with a sustained increase in the normal respiratory symptoms of dyspnoea, cough, and sputum volume and purulence. It h...
Detailed Description
Acute exacerbations of COPD remain a common cause of morbidity and are associated with a sustained increase in the respiratory symptoms of dyspnoea, cough, sputum volume and sputum purulence. Cough is...
Eligibility Criteria
Inclusion
- Male/females aged between 40-80 years.
- Previous diagnosis of COPD.
- Acute exacerbation of COPD requiring treatment with antibiotics and/or corticosteroids.
- Symptoms of increased breathlessness, cough, sputum volume or sputum purulence.
- Acute exacerbation of COPD hospitalised within 48 hrs of study participation.
- On a stable therapeutic regimen for COPD for 8 weeks prior to inclusion.
- Known history of cigarette smoking at least 10 pack yrs.
- Willing and able to comply with study procedures.
- Able to provide written informed consent to participate.
Exclusion
- Acute exacerbation of COPD within 8 weeks prior to inclusion.
- Clinically significant or unstable concurrent disease e.g. left ventricular failure, diabetes mellitus.
- On long-term oxygen therapy.
Key Trial Info
Start Date :
January 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2013
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT01405222
Start Date
January 1 2012
End Date
July 1 2013
Last Update
July 15 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Redspiratory medicine, Clinical trials Unit, Castle Hill hospital
Cottingham, East Yorkshire, United Kingdom, HU16 5JQ